Metformin is the most commonly prescribed first-line medicine to lower A1C, but it is not always the strongest. GLP-1 receptor agonists like semaglutide and tirzepatide typically produce larger A1C reductions, while SGLT2 inhibitors add heart and kidney protection. The “best” medicine depends on your starting A1C, weight, other health conditions, and cost.
How A1C-Lowering Medicines Work
A1C reflects your average blood glucose over 2 to 3 months. Medicines lower A1C by reducing how much glucose your liver releases, improving how your cells use insulin, slowing digestion, increasing insulin secretion, or flushing glucose through urine. Each drug class does one or more of these things.
Before adding medicine, most guidelines recommend 3 to 6 months of lifestyle therapy. See our A1C levels guide for target ranges and what your number means.
Metformin: The Standard First-Line Medicine
Metformin is the American Diabetes Association’s preferred first drug for type 2 diabetes and is also used off-label for prediabetes in high-risk adults. It lowers A1C by 1.0 to 1.5 percentage points on average.
Metformin works mainly by reducing glucose production in the liver and improving insulin sensitivity in muscle cells. It is inexpensive, does not cause weight gain or low blood sugar on its own, and has more than 60 years of clinical use behind it. Common side effects are gastrointestinal (nausea, diarrhea) and usually fade within weeks.
GLP-1 Receptor Agonists: The Largest A1C Reductions
GLP-1 agonists mimic a gut hormone that triggers insulin release, slows stomach emptying, and reduces appetite. This class often produces the largest A1C drops outside of insulin.
- Semaglutide (Ozempic, Rybelsus): weekly injection or daily pill, lowers A1C by 1.5 to 1.8 points
- Tirzepatide (Mounjaro): dual GLP-1/GIP agonist, lowers A1C by up to 2.0 to 2.4 points
- Dulaglutide (Trulicity), Liraglutide (Victoza): weekly or daily injections with proven A1C and cardiovascular benefit
These drugs also support 5 to 20 percent weight loss, which compounds the A1C benefit.
SGLT2 Inhibitors: A1C Plus Heart and Kidney Benefits
SGLT2 inhibitors (empagliflozin, dapagliflozin, canagliflozin) make the kidneys excrete more glucose in urine. A1C reductions are modest (0.5 to 1.0 points), but these drugs reduce heart failure hospitalizations and slow kidney disease progression.
They are often added when A1C control is paired with cardiovascular or kidney risk. Side effects include genital yeast infections and a small risk of diabetic ketoacidosis.
Comparison of A1C-Lowering Medicines
| Drug Class | Typical A1C Drop | Weight Effect | Key Benefit |
|---|---|---|---|
| Metformin | 1.0 to 1.5% | Neutral/slight loss | Cheap, safe, first-line |
| GLP-1 agonists | 1.5 to 2.4% | Significant loss | Largest A1C drop, weight loss |
| SGLT2 inhibitors | 0.5 to 1.0% | Slight loss | Heart and kidney protection |
| DPP-4 inhibitors | 0.5 to 0.8% | Neutral | Well tolerated, oral |
| Sulfonylureas | 1.0 to 1.5% | Gain | Cheap, oral, but hypoglycemia risk |
| Insulin | No ceiling | Gain | Works for any A1C level |
Which Medicine Is “Best” for You?
The ADA’s 2024 Standards of Care recommend individualizing therapy:
- If you have heart disease or heart failure, start with a GLP-1 or SGLT2
- If you have chronic kidney disease, prioritize SGLT2 inhibitors
- If weight loss is a goal, GLP-1 agonists or tirzepatide
- If cost is primary, metformin plus a sulfonylurea
- If you need rapid A1C control (A1C above 10%), insulin is often added
Lifestyle Still Matters
No medicine replaces diet, exercise, and weight loss. A 5 to 7 percent body weight loss can lower A1C by 0.5 to 1.0 points on its own. Combining lifestyle changes with medicine often produces the best results. Read our guide on reversing prediabetes for evidence-based lifestyle strategies.
The Bottom Line
Metformin remains the best first medicine for most adults with high A1C because it is effective, safe, and cheap. GLP-1 agonists (semaglutide, tirzepatide) produce the largest A1C reductions and are preferred when weight loss or heart disease is a factor. SGLT2 inhibitors are best when kidney or heart failure is present. Work with your doctor to match the drug to your health profile.
